MultiQure S.A. (WSE:MQR)

Market Cap	36.24M +33.7%
Revenue (ttm)	n/a
Net Income	-10.73M
EPS	-1.57
Shares Out	12.24M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,480
Open	2.950
Previous Close	2.975
Day's Range	2.935 - 3.060
52-Week Range	1.353 - 7.770
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About MultiQure

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G, which targets the GARP-TGFβ1 complex; PB004, an anticancer drug based on an anti-ROR1 antibody; and PB003A, a therapy that targets the αVβ8 integrin. The company was formerly known as Pure Biologics S.A. and changed its name to MultiQure S.A. in August 2026. The company was founded in 2010 and is based in Wroclaw, Poland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2010
• Employees: 7
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: MQR

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 15, 2026

Data Sources Report a data error